BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1183 related articles for article (PubMed ID: 24482054)

  • 1. Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography.
    García E; Almería C; Unzué L; Jiménez-Quevedo P; Cuadrado A; Macaya C
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):868-76. PubMed ID: 24482054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal prosthesis sizing in transcatheter aortic valve implantation by exclusive use of three-dimensional transoesophageal echocardiography.
    Kretzschmar D; Lauten A; Goebel B; Doenst T; Poerner TC; Ferrari M; Figulla HR; Hamadanchi A
    Clin Physiol Funct Imaging; 2016 Mar; 36(2):99-105. PubMed ID: 25316588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
    Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
    Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfemoral TAVI without pre-dilatation using balloon-expandable devices: a case-matched analysis.
    Conradi L; Schaefer A; Seiffert M; Schirmer J; Schaefer U; Schön G; Blankenberg S; Reichenspurner H; Treede H; Diemert P
    Clin Res Cardiol; 2015 Sep; 104(9):735-42. PubMed ID: 25725778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve.
    García E; Martín P; Hernández R; Rodríguez V; Fernández A; Gama V; Almería C; Macaya C
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):791-5. PubMed ID: 24285561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of three-dimensional transesophageal echocardiography on prosthesis sizing for transcatheter aortic valve implantation.
    Husser O; Rauch S; Endemann DH; Resch M; Nunez J; Bodi V; Hilker M; Schmid C; Riegger GA; Luchner A; Hengstenberg C
    Catheter Cardiovasc Interv; 2012 Nov; 80(6):956-63. PubMed ID: 22419651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DynaCT-guided anatomical rotation of the SAPIEN XT valve during transapical aortic valve implantation: proof of concept.
    Blumenstein JM; Van Linden A; Moellmann H; Seeburger J; Rastan A; Kim WK; Mohr FW; Kempfert J; Walther T
    Thorac Cardiovasc Surg; 2013 Aug; 61(5):409-13. PubMed ID: 23247690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prosthesis-patient mismatch after transcatheter aortic valve implantation: impact of 2D-transthoracic echocardiography versus 3D-transesophageal echocardiography.
    da Silva C; Sahlen A; Winter R; Bäck M; Rück A; Settergren M; Manouras A; Shahgaldi K
    Int J Cardiovasc Imaging; 2014 Dec; 30(8):1549-57. PubMed ID: 25102782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective "oversizing" strategy of the Edwards SAPIEN bioprosthesis: results and impact on aortic regurgitation.
    Samim M; Stella PR; Agostoni P; Kluin J; Ramjankhan F; Sieswerda G; Budde R; van der Linden M; Juthier F; Banfi C; Hurt C; Samim M; Hillaert M; van Herwerden L; Bertrand ME; Doevendans PA; Van Belle E
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):398-405. PubMed ID: 22377664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.
    Freeman M; Rodés-Cabau J; Urena M; DeLarochelliere R; Dumont E; Masson JB; Willson AB; Binder RK; Toggweiler S; Leipsic J; Wood DA; Webb JG
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):664-70. PubMed ID: 22744829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic outcomes of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN XT valves: the comparison of two bioprosthesis implanted in a single centre.
    Kaya D; Tanriverdi Z; Dursun H; Colluoglu T
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1371-1378. PubMed ID: 27278270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfemoral aortic valve implantation of Edwards SAPIEN 3 without predilatation.
    Kim WK; Praz F; Blumenstein J; Liebetrau C; Gaede L; Van Linden A; Hamm C; Walther T; Windecker S; Möllmann H
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):E38-E43. PubMed ID: 26945934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applicability of next generation balloon-expandable transcatheter heart valves in aortic annuli exceeding formally approved dimensions.
    Schaefer A; Linder M; Treede H; Deuschl F; Schofer N; Seiffert M; Schneeberger Y; Blankenberg S; Reichenspurner H; Schaefer U; Conradi L
    Clin Res Cardiol; 2016 Jul; 105(7):585-91. PubMed ID: 26680213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
    Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT.
    Yang TH; Webb JG; Blanke P; Dvir D; Hansson NC; Nørgaard BL; Thompson CR; Thomas M; Wendler O; Vahanian A; Himbert D; Kodali SK; Hahn RT; Thourani VH; Schymik G; Precious B; Berger A; Wood DA; Pibarot P; Rodés-Cabau J; Jaber WA; Leon MB; Walther T; Leipsic J
    JACC Cardiovasc Interv; 2015 Mar; 8(3):462-471. PubMed ID: 25790764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter aortic valve implantation for treatment of patients with degenerated aortic bioprostheses--valve-in-valve technique.
    Gotzmann M; Mügge A; Bojara W
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):1000-6. PubMed ID: 20824744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparatory balloon aortic valvuloplasty during transcatheter aortic valve implantation for improved valve sizing.
    Patsalis PC; Al-Rashid F; Neumann T; Plicht B; Hildebrandt HA; Wendt D; Thielmann M; Jakob HG; Heusch G; Erbel R; Kahlert P
    JACC Cardiovasc Interv; 2013 Sep; 6(9):965-71. PubMed ID: 24050862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transesophageal echocardiographic scoring for transcatheter aortic valve implantation: impact of aortic cusp calcification on postoperative aortic regurgitation.
    Colli A; D'Amico R; Kempfert J; Borger MA; Mohr FW; Walther T
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1229-35. PubMed ID: 22014345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation.
    Binder RK; Webb JG; Toggweiler S; Freeman M; Barbanti M; Willson AB; Alhassan D; Hague CJ; Wood DA; Leipsic J
    JACC Cardiovasc Interv; 2013 May; 6(5):462-8. PubMed ID: 23702010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.